Loading…

14-Week toxicity and cell proliferation of methyleugenol administered by gavage to F344 rats and B6C3F1 mice

Methyleugenol, a food flavor and fragrance agent, was tested for toxicity in male and female F344/N rats and B6C3F1 mice. Groups of 10 males and 10 females per sex per species were administered 0, 10, 30, 100, 300 or 1000 mg methyleugenol/kg body weight in 0.5% aqueous methylcellulose by gavage, 5 d...

Full description

Saved in:
Bibliographic Details
Published in:Food and chemical toxicology 2001-04, Vol.39 (4), p.303-316
Main Authors: Abdo, K.M, Cunningham, M.L, Snell, M.L, Herbert, R.A, Travlos, G.S, Eldridge, S.R, Bucher, J.R
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c420t-c0b88ef8258717c75d2c688fe8a44bb0c21177ee9f0a62177023c916cbc37ab73
cites cdi_FETCH-LOGICAL-c420t-c0b88ef8258717c75d2c688fe8a44bb0c21177ee9f0a62177023c916cbc37ab73
container_end_page 316
container_issue 4
container_start_page 303
container_title Food and chemical toxicology
container_volume 39
creator Abdo, K.M
Cunningham, M.L
Snell, M.L
Herbert, R.A
Travlos, G.S
Eldridge, S.R
Bucher, J.R
description Methyleugenol, a food flavor and fragrance agent, was tested for toxicity in male and female F344/N rats and B6C3F1 mice. Groups of 10 males and 10 females per sex per species were administered 0, 10, 30, 100, 300 or 1000 mg methyleugenol/kg body weight in 0.5% aqueous methylcellulose by gavage, 5 days per week for 14 weeks. Additional groups of rats and mice of each sex were dosed similarly and used for hematology and clinical chemistry studies. Groups of 10 male and 10 female rats and mice received the vehicle by gavage on the same dosing schedule and served as vehicle controls. For serum gastrin, gastric pH and cell proliferation studies groups of 10 female rats were given 0, 37, 75 or 150 mg/kg, once daily 5 days per week for 30 or 90 days or 300 or 1000 mg/kg for 30 days; male mice were given 0, 9, 18.5, 37, 75, 150 or 300 mg/kg for 30 or 90 days. For the gastrin, pH and cell proliferation studies, groups of 10 female rats and 10 male mice were given the vehicle for 30 or 90 days and served as controls. Methyleugenol administration to rats induced erythrocyte microcytosis and thrombocytosis in male and female rats. It also caused an increase in serum alanine aminotransferase and sorbitol dehydrogenase activities and bile acid concentration, suggesting hepatocellular injury, cholestasis or altered hepatic function. Additionally, methyleugenol induced hypoproteinemia and hypoalbuminemia, evidenced by decreased total protein and albumin concentrations in both male and female rats, suggesting in inefficiency of dietary protein utilization due to methyleugenol-induced toxic effects on the liver and glandular stomach of rats and mice. The increase in gastrin and gastric pH of rats and mice given methyleugenol suggests that gastrin feedback was impaired and resulted in conditions not conducive to protein digestion. In rats, methyleugenol caused an increase in the incidences of hepatocyte cytologic alteration, cytomegaly, Kupffer cell pigmentation, mixed foci of cellular alteration and bile duct hyperplasia of the liver and atrophy and chronic inflammation of the mucosa of the glandular stomach. In mice, it caused an increase in the incidence of cytologic alteration, necrosis, bile duct hyperplasia and subacute inflammation of the liver and atrophy, degeneration, necrosis, edema, mitotic alteration, and cystic glands of the fundic region of the glandular stomach. The increased incidences of adrenal gland cortical hypertrophy and/or cytoplasmic alteration in t
doi_str_mv 10.1016/S0278-6915(00)00143-5
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17870192</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0278691500001435</els_id><sourcerecordid>17870192</sourcerecordid><originalsourceid>FETCH-LOGICAL-c420t-c0b88ef8258717c75d2c688fe8a44bb0c21177ee9f0a62177023c916cbc37ab73</originalsourceid><addsrcrecordid>eNqFkE2LFDEQhoMo7rj6E5SAIHporUp3J-mT6OCosOBBxWNIV1eP0f7YTXoW59-b-WA9ekoOz_tW1SPEU4TXCKjffAVlbKEbrF8CvALAqizqe2KF1pSFLmu8L1Z3yIV4lNIvADBo9ENxgaiaujJ2JQasih_Mv-Uy_wkUlr30UyeJh0Fex3kIPUe_hHmScy9HXn7uB95teZoH6bsxTCEtHLmT7V5u_a3fcu6Rm7KqZI6lY9d7vS43KMdA_Fg86P2Q-Mn5vRTfNx--rT8VV18-fl6_uyqoUrAUBK213FtV27wvmbpTpK3t2fqqalsghWgMc9OD1yp_QZXUoKaWSuNbU16KF6fefMLNjtPixpAON_mJ511yaKwBbFQG6xNIcU4pcu-uYxh93DsEd9DsjprdwaEDcEfNrs65Z-cBu3bk7l_q7DUDz8-AT-SHPvqJQrrjGg1gD-PfnijOMm4DR5co8ETchci0uG4O_1nkLyGol7U</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17870192</pqid></control><display><type>article</type><title>14-Week toxicity and cell proliferation of methyleugenol administered by gavage to F344 rats and B6C3F1 mice</title><source>ScienceDirect Journals</source><creator>Abdo, K.M ; Cunningham, M.L ; Snell, M.L ; Herbert, R.A ; Travlos, G.S ; Eldridge, S.R ; Bucher, J.R</creator><creatorcontrib>Abdo, K.M ; Cunningham, M.L ; Snell, M.L ; Herbert, R.A ; Travlos, G.S ; Eldridge, S.R ; Bucher, J.R</creatorcontrib><description>Methyleugenol, a food flavor and fragrance agent, was tested for toxicity in male and female F344/N rats and B6C3F1 mice. Groups of 10 males and 10 females per sex per species were administered 0, 10, 30, 100, 300 or 1000 mg methyleugenol/kg body weight in 0.5% aqueous methylcellulose by gavage, 5 days per week for 14 weeks. Additional groups of rats and mice of each sex were dosed similarly and used for hematology and clinical chemistry studies. Groups of 10 male and 10 female rats and mice received the vehicle by gavage on the same dosing schedule and served as vehicle controls. For serum gastrin, gastric pH and cell proliferation studies groups of 10 female rats were given 0, 37, 75 or 150 mg/kg, once daily 5 days per week for 30 or 90 days or 300 or 1000 mg/kg for 30 days; male mice were given 0, 9, 18.5, 37, 75, 150 or 300 mg/kg for 30 or 90 days. For the gastrin, pH and cell proliferation studies, groups of 10 female rats and 10 male mice were given the vehicle for 30 or 90 days and served as controls. Methyleugenol administration to rats induced erythrocyte microcytosis and thrombocytosis in male and female rats. It also caused an increase in serum alanine aminotransferase and sorbitol dehydrogenase activities and bile acid concentration, suggesting hepatocellular injury, cholestasis or altered hepatic function. Additionally, methyleugenol induced hypoproteinemia and hypoalbuminemia, evidenced by decreased total protein and albumin concentrations in both male and female rats, suggesting in inefficiency of dietary protein utilization due to methyleugenol-induced toxic effects on the liver and glandular stomach of rats and mice. The increase in gastrin and gastric pH of rats and mice given methyleugenol suggests that gastrin feedback was impaired and resulted in conditions not conducive to protein digestion. In rats, methyleugenol caused an increase in the incidences of hepatocyte cytologic alteration, cytomegaly, Kupffer cell pigmentation, mixed foci of cellular alteration and bile duct hyperplasia of the liver and atrophy and chronic inflammation of the mucosa of the glandular stomach. In mice, it caused an increase in the incidence of cytologic alteration, necrosis, bile duct hyperplasia and subacute inflammation of the liver and atrophy, degeneration, necrosis, edema, mitotic alteration, and cystic glands of the fundic region of the glandular stomach. The increased incidences of adrenal gland cortical hypertrophy and/or cytoplasmic alteration in the submandibular salivary glands, adrenal glands, testis and uterus of rats were considered secondary to the chemical-related effects observed in the liver and glandular stomach. Based on mortality, body weight gain, clinical chemistry and gross and microscopic evaluation of tissues of rats and mice, the no-observed-effect level (NOEL) of methyleugenol for both species was estimated at 10 mg/kg.</description><identifier>ISSN: 0278-6915</identifier><identifier>EISSN: 1873-6351</identifier><identifier>DOI: 10.1016/S0278-6915(00)00143-5</identifier><identifier>PMID: 11295478</identifier><identifier>CODEN: FCTOD7</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Alanine Transaminase - blood ; Animals ; Biological and medical sciences ; Body Weight ; Cell Division - drug effects ; Cell proliferation ; Cytotoxicity Tests, Immunologic ; Dose-Response Relationship, Drug ; Erythrocytes ; Essential oils ; Eugenol - analogs &amp; derivatives ; Eugenol - toxicity ; Female ; Food toxicology ; Gastric Mucosa - drug effects ; Gastric Mucosa - metabolism ; Gastric Mucosa - pathology ; Gastrins - blood ; Hydrogen-Ion Concentration ; L-Iditol 2-Dehydrogenase - metabolism ; Liver - drug effects ; Liver - enzymology ; Liver - pathology ; Male ; Medical sciences ; Methyleugenol ; Mice ; Mutagens - toxicity ; Organ Size - drug effects ; Organ Specificity ; p-Alkoxyallylbenzenes ; Rats ; Rats, Inbred F344 ; Thrombocytosis ; Toxicology</subject><ispartof>Food and chemical toxicology, 2001-04, Vol.39 (4), p.303-316</ispartof><rights>2001 Elsevier Science Ltd</rights><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c420t-c0b88ef8258717c75d2c688fe8a44bb0c21177ee9f0a62177023c916cbc37ab73</citedby><cites>FETCH-LOGICAL-c420t-c0b88ef8258717c75d2c688fe8a44bb0c21177ee9f0a62177023c916cbc37ab73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=960082$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11295478$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Abdo, K.M</creatorcontrib><creatorcontrib>Cunningham, M.L</creatorcontrib><creatorcontrib>Snell, M.L</creatorcontrib><creatorcontrib>Herbert, R.A</creatorcontrib><creatorcontrib>Travlos, G.S</creatorcontrib><creatorcontrib>Eldridge, S.R</creatorcontrib><creatorcontrib>Bucher, J.R</creatorcontrib><title>14-Week toxicity and cell proliferation of methyleugenol administered by gavage to F344 rats and B6C3F1 mice</title><title>Food and chemical toxicology</title><addtitle>Food Chem Toxicol</addtitle><description>Methyleugenol, a food flavor and fragrance agent, was tested for toxicity in male and female F344/N rats and B6C3F1 mice. Groups of 10 males and 10 females per sex per species were administered 0, 10, 30, 100, 300 or 1000 mg methyleugenol/kg body weight in 0.5% aqueous methylcellulose by gavage, 5 days per week for 14 weeks. Additional groups of rats and mice of each sex were dosed similarly and used for hematology and clinical chemistry studies. Groups of 10 male and 10 female rats and mice received the vehicle by gavage on the same dosing schedule and served as vehicle controls. For serum gastrin, gastric pH and cell proliferation studies groups of 10 female rats were given 0, 37, 75 or 150 mg/kg, once daily 5 days per week for 30 or 90 days or 300 or 1000 mg/kg for 30 days; male mice were given 0, 9, 18.5, 37, 75, 150 or 300 mg/kg for 30 or 90 days. For the gastrin, pH and cell proliferation studies, groups of 10 female rats and 10 male mice were given the vehicle for 30 or 90 days and served as controls. Methyleugenol administration to rats induced erythrocyte microcytosis and thrombocytosis in male and female rats. It also caused an increase in serum alanine aminotransferase and sorbitol dehydrogenase activities and bile acid concentration, suggesting hepatocellular injury, cholestasis or altered hepatic function. Additionally, methyleugenol induced hypoproteinemia and hypoalbuminemia, evidenced by decreased total protein and albumin concentrations in both male and female rats, suggesting in inefficiency of dietary protein utilization due to methyleugenol-induced toxic effects on the liver and glandular stomach of rats and mice. The increase in gastrin and gastric pH of rats and mice given methyleugenol suggests that gastrin feedback was impaired and resulted in conditions not conducive to protein digestion. In rats, methyleugenol caused an increase in the incidences of hepatocyte cytologic alteration, cytomegaly, Kupffer cell pigmentation, mixed foci of cellular alteration and bile duct hyperplasia of the liver and atrophy and chronic inflammation of the mucosa of the glandular stomach. In mice, it caused an increase in the incidence of cytologic alteration, necrosis, bile duct hyperplasia and subacute inflammation of the liver and atrophy, degeneration, necrosis, edema, mitotic alteration, and cystic glands of the fundic region of the glandular stomach. The increased incidences of adrenal gland cortical hypertrophy and/or cytoplasmic alteration in the submandibular salivary glands, adrenal glands, testis and uterus of rats were considered secondary to the chemical-related effects observed in the liver and glandular stomach. Based on mortality, body weight gain, clinical chemistry and gross and microscopic evaluation of tissues of rats and mice, the no-observed-effect level (NOEL) of methyleugenol for both species was estimated at 10 mg/kg.</description><subject>Alanine Transaminase - blood</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Body Weight</subject><subject>Cell Division - drug effects</subject><subject>Cell proliferation</subject><subject>Cytotoxicity Tests, Immunologic</subject><subject>Dose-Response Relationship, Drug</subject><subject>Erythrocytes</subject><subject>Essential oils</subject><subject>Eugenol - analogs &amp; derivatives</subject><subject>Eugenol - toxicity</subject><subject>Female</subject><subject>Food toxicology</subject><subject>Gastric Mucosa - drug effects</subject><subject>Gastric Mucosa - metabolism</subject><subject>Gastric Mucosa - pathology</subject><subject>Gastrins - blood</subject><subject>Hydrogen-Ion Concentration</subject><subject>L-Iditol 2-Dehydrogenase - metabolism</subject><subject>Liver - drug effects</subject><subject>Liver - enzymology</subject><subject>Liver - pathology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Methyleugenol</subject><subject>Mice</subject><subject>Mutagens - toxicity</subject><subject>Organ Size - drug effects</subject><subject>Organ Specificity</subject><subject>p-Alkoxyallylbenzenes</subject><subject>Rats</subject><subject>Rats, Inbred F344</subject><subject>Thrombocytosis</subject><subject>Toxicology</subject><issn>0278-6915</issn><issn>1873-6351</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNqFkE2LFDEQhoMo7rj6E5SAIHporUp3J-mT6OCosOBBxWNIV1eP0f7YTXoW59-b-WA9ekoOz_tW1SPEU4TXCKjffAVlbKEbrF8CvALAqizqe2KF1pSFLmu8L1Z3yIV4lNIvADBo9ENxgaiaujJ2JQasih_Mv-Uy_wkUlr30UyeJh0Fex3kIPUe_hHmScy9HXn7uB95teZoH6bsxTCEtHLmT7V5u_a3fcu6Rm7KqZI6lY9d7vS43KMdA_Fg86P2Q-Mn5vRTfNx--rT8VV18-fl6_uyqoUrAUBK213FtV27wvmbpTpK3t2fqqalsghWgMc9OD1yp_QZXUoKaWSuNbU16KF6fefMLNjtPixpAON_mJ511yaKwBbFQG6xNIcU4pcu-uYxh93DsEd9DsjprdwaEDcEfNrs65Z-cBu3bk7l_q7DUDz8-AT-SHPvqJQrrjGg1gD-PfnijOMm4DR5co8ETchci0uG4O_1nkLyGol7U</recordid><startdate>20010401</startdate><enddate>20010401</enddate><creator>Abdo, K.M</creator><creator>Cunningham, M.L</creator><creator>Snell, M.L</creator><creator>Herbert, R.A</creator><creator>Travlos, G.S</creator><creator>Eldridge, S.R</creator><creator>Bucher, J.R</creator><general>Elsevier Ltd</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>20010401</creationdate><title>14-Week toxicity and cell proliferation of methyleugenol administered by gavage to F344 rats and B6C3F1 mice</title><author>Abdo, K.M ; Cunningham, M.L ; Snell, M.L ; Herbert, R.A ; Travlos, G.S ; Eldridge, S.R ; Bucher, J.R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c420t-c0b88ef8258717c75d2c688fe8a44bb0c21177ee9f0a62177023c916cbc37ab73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Alanine Transaminase - blood</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Body Weight</topic><topic>Cell Division - drug effects</topic><topic>Cell proliferation</topic><topic>Cytotoxicity Tests, Immunologic</topic><topic>Dose-Response Relationship, Drug</topic><topic>Erythrocytes</topic><topic>Essential oils</topic><topic>Eugenol - analogs &amp; derivatives</topic><topic>Eugenol - toxicity</topic><topic>Female</topic><topic>Food toxicology</topic><topic>Gastric Mucosa - drug effects</topic><topic>Gastric Mucosa - metabolism</topic><topic>Gastric Mucosa - pathology</topic><topic>Gastrins - blood</topic><topic>Hydrogen-Ion Concentration</topic><topic>L-Iditol 2-Dehydrogenase - metabolism</topic><topic>Liver - drug effects</topic><topic>Liver - enzymology</topic><topic>Liver - pathology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Methyleugenol</topic><topic>Mice</topic><topic>Mutagens - toxicity</topic><topic>Organ Size - drug effects</topic><topic>Organ Specificity</topic><topic>p-Alkoxyallylbenzenes</topic><topic>Rats</topic><topic>Rats, Inbred F344</topic><topic>Thrombocytosis</topic><topic>Toxicology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Abdo, K.M</creatorcontrib><creatorcontrib>Cunningham, M.L</creatorcontrib><creatorcontrib>Snell, M.L</creatorcontrib><creatorcontrib>Herbert, R.A</creatorcontrib><creatorcontrib>Travlos, G.S</creatorcontrib><creatorcontrib>Eldridge, S.R</creatorcontrib><creatorcontrib>Bucher, J.R</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Food and chemical toxicology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Abdo, K.M</au><au>Cunningham, M.L</au><au>Snell, M.L</au><au>Herbert, R.A</au><au>Travlos, G.S</au><au>Eldridge, S.R</au><au>Bucher, J.R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>14-Week toxicity and cell proliferation of methyleugenol administered by gavage to F344 rats and B6C3F1 mice</atitle><jtitle>Food and chemical toxicology</jtitle><addtitle>Food Chem Toxicol</addtitle><date>2001-04-01</date><risdate>2001</risdate><volume>39</volume><issue>4</issue><spage>303</spage><epage>316</epage><pages>303-316</pages><issn>0278-6915</issn><eissn>1873-6351</eissn><coden>FCTOD7</coden><abstract>Methyleugenol, a food flavor and fragrance agent, was tested for toxicity in male and female F344/N rats and B6C3F1 mice. Groups of 10 males and 10 females per sex per species were administered 0, 10, 30, 100, 300 or 1000 mg methyleugenol/kg body weight in 0.5% aqueous methylcellulose by gavage, 5 days per week for 14 weeks. Additional groups of rats and mice of each sex were dosed similarly and used for hematology and clinical chemistry studies. Groups of 10 male and 10 female rats and mice received the vehicle by gavage on the same dosing schedule and served as vehicle controls. For serum gastrin, gastric pH and cell proliferation studies groups of 10 female rats were given 0, 37, 75 or 150 mg/kg, once daily 5 days per week for 30 or 90 days or 300 or 1000 mg/kg for 30 days; male mice were given 0, 9, 18.5, 37, 75, 150 or 300 mg/kg for 30 or 90 days. For the gastrin, pH and cell proliferation studies, groups of 10 female rats and 10 male mice were given the vehicle for 30 or 90 days and served as controls. Methyleugenol administration to rats induced erythrocyte microcytosis and thrombocytosis in male and female rats. It also caused an increase in serum alanine aminotransferase and sorbitol dehydrogenase activities and bile acid concentration, suggesting hepatocellular injury, cholestasis or altered hepatic function. Additionally, methyleugenol induced hypoproteinemia and hypoalbuminemia, evidenced by decreased total protein and albumin concentrations in both male and female rats, suggesting in inefficiency of dietary protein utilization due to methyleugenol-induced toxic effects on the liver and glandular stomach of rats and mice. The increase in gastrin and gastric pH of rats and mice given methyleugenol suggests that gastrin feedback was impaired and resulted in conditions not conducive to protein digestion. In rats, methyleugenol caused an increase in the incidences of hepatocyte cytologic alteration, cytomegaly, Kupffer cell pigmentation, mixed foci of cellular alteration and bile duct hyperplasia of the liver and atrophy and chronic inflammation of the mucosa of the glandular stomach. In mice, it caused an increase in the incidence of cytologic alteration, necrosis, bile duct hyperplasia and subacute inflammation of the liver and atrophy, degeneration, necrosis, edema, mitotic alteration, and cystic glands of the fundic region of the glandular stomach. The increased incidences of adrenal gland cortical hypertrophy and/or cytoplasmic alteration in the submandibular salivary glands, adrenal glands, testis and uterus of rats were considered secondary to the chemical-related effects observed in the liver and glandular stomach. Based on mortality, body weight gain, clinical chemistry and gross and microscopic evaluation of tissues of rats and mice, the no-observed-effect level (NOEL) of methyleugenol for both species was estimated at 10 mg/kg.</abstract><cop>Oxford</cop><cop>New York, NY</cop><pub>Elsevier Ltd</pub><pmid>11295478</pmid><doi>10.1016/S0278-6915(00)00143-5</doi><tpages>14</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0278-6915
ispartof Food and chemical toxicology, 2001-04, Vol.39 (4), p.303-316
issn 0278-6915
1873-6351
language eng
recordid cdi_proquest_miscellaneous_17870192
source ScienceDirect Journals
subjects Alanine Transaminase - blood
Animals
Biological and medical sciences
Body Weight
Cell Division - drug effects
Cell proliferation
Cytotoxicity Tests, Immunologic
Dose-Response Relationship, Drug
Erythrocytes
Essential oils
Eugenol - analogs & derivatives
Eugenol - toxicity
Female
Food toxicology
Gastric Mucosa - drug effects
Gastric Mucosa - metabolism
Gastric Mucosa - pathology
Gastrins - blood
Hydrogen-Ion Concentration
L-Iditol 2-Dehydrogenase - metabolism
Liver - drug effects
Liver - enzymology
Liver - pathology
Male
Medical sciences
Methyleugenol
Mice
Mutagens - toxicity
Organ Size - drug effects
Organ Specificity
p-Alkoxyallylbenzenes
Rats
Rats, Inbred F344
Thrombocytosis
Toxicology
title 14-Week toxicity and cell proliferation of methyleugenol administered by gavage to F344 rats and B6C3F1 mice
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T21%3A55%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=14-Week%20toxicity%20and%20cell%20proliferation%20of%20methyleugenol%20administered%20by%20gavage%20to%20F344%20rats%20and%20B6C3F1%20mice&rft.jtitle=Food%20and%20chemical%20toxicology&rft.au=Abdo,%20K.M&rft.date=2001-04-01&rft.volume=39&rft.issue=4&rft.spage=303&rft.epage=316&rft.pages=303-316&rft.issn=0278-6915&rft.eissn=1873-6351&rft.coden=FCTOD7&rft_id=info:doi/10.1016/S0278-6915(00)00143-5&rft_dat=%3Cproquest_cross%3E17870192%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c420t-c0b88ef8258717c75d2c688fe8a44bb0c21177ee9f0a62177023c916cbc37ab73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17870192&rft_id=info:pmid/11295478&rfr_iscdi=true